| Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress NH Kim, YH Cha, J Lee, SH Lee, JH Yang, JS Yun, ES Cho, X Zhang, ... Nature communications 8 (1), 14374, 2017 | 181 | 2017 |
| The pentose phosphate pathway as a potential target for cancer therapy ES Cho, YH Cha, HS Kim, NH Kim, JI Yook Biomolecules & therapeutics 26 (1), 29, 2018 | 179 | 2018 |
| MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling YH Cha, NH Kim, C Park, I Lee, HS Kim, JI Yook Cell cycle 11 (7), 1273-1281, 2012 | 137 | 2012 |
| p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells NH Kim, YH Cha, S Eun Kang, Y Mi Lee, I Lee, S Young Cha, ... Cell cycle 12 (10), 1578-1587, 2013 | 129 | 2013 |
| Helicobacter pylori CagA promotes Snail-mediated epithelial–mesenchymal transition by reducing GSK-3 activity DG Lee, HS Kim, YS Lee, S Kim, SY Cha, I Ota, NH Kim, YH Cha, ... Nature communications 5 (1), 4423, 2014 | 98 | 2014 |
| Targeting mutant KRAS with CRISPR-Cas9 controls tumor growth W Kim, S Lee, HS Kim, M Song, YH Cha, YH Kim, J Shin, ES Lee, Y Joo, ... Genome research 28 (3), 374-382, 2018 | 74 | 2018 |
| Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner Y Lee, NH Kim, ES Cho, JH Yang, YH Cha, HE Kang, JS Yun, SB Cho, ... Nature communications 9 (1), 2301, 2018 | 66 | 2018 |
| Catabolic metabolism during cancer EMT YH Cha, JI Yook, HS Kim, NH Kim Archives of pharmacal research 38, 313-320, 2015 | 59 | 2015 |
| ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer I Jun, HS Park, H Piao, JW Han, MJ An, BG Yun, X Zhang, YH Cha, ... British journal of cancer 117 (12), 1798-1809, 2017 | 48 | 2017 |
| Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction SY Ahn, NH Kim, K Lee, YH Cha, JH Yang, SY Cha, ES Cho, Y Lee, ... Oncotarget 8 (19), 31842, 2017 | 34 | 2017 |
| Frequent oncogenic BRAF V600E mutation in odontogenic keratocyst YH Cha, ES Cho, HE Kang, J Ko, W Nam, HJ Kim, NH Kim, HS Kim, ... Oral Oncology 74, 62-67, 2017 | 29 | 2017 |
| Revisiting radial forearm free flap for successful venous drainage YH Cha, W Nam, IH Cha, HJ Kim Maxillofacial Plastic and Reconstructive Surgery 39, 1-4, 2017 | 28 | 2017 |
| Snail augments fatty acid oxidation by suppression of mitochondrial ACC2 during cancer progression JH Yang, NH Kim, JS Yun, ES Cho, YH Cha, SB Cho, SH Lee, SY Cha, ... Life Science Alliance 3 (7), 2020 | 26 | 2020 |
| Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas Y Cui, HS Kim, ES Cho, D Han, JA Park, JY Park, W Nam, HJ Kim, IH Cha, ... PloS one 16 (9), e0256979, 2021 | 24 | 2021 |
| Anti-helminthic niclosamide inhibits Ras-driven oncogenic transformation via activation of GSK-3 SY Ahn, JH Yang, NH Kim, K Lee, YH Cha, JS Yun, HE Kang, Y Lee, ... Oncotarget 8 (19), 31856, 2017 | 24 | 2017 |
| Anatomy of the external branch of the superior laryngeal nerve in Asian population YH Cha, SY Moon, O Jehoon, T Tansatit, HM Yang Scientific Reports 7 (1), 14952, 2017 | 22 | 2017 |
| Teriparatide therapy for severe, refractory osteoradionecrosis of the jaw YH Cha, N Hong, Y Rhee, IH Cha Osteoporosis International 29, 987-992, 2018 | 17 | 2018 |
| A platform technique for growth factor delivery with novel mode of action NH Kim, YH Cha, HS Kim, SE Lee, JK Huh, JK Kim, JM Kim, JK Ryu, ... Biomaterials 35 (37), 9888-9896, 2014 | 14 | 2014 |
| Robot-assisted submandibular gland excision via modified facelift incision SW Jung, YK Kim, YH Cha, YW Koh, W Nam Maxillofacial Plastic and Reconstructive Surgery 39, 1-6, 2017 | 12 | 2017 |
| Analysis of treatment patterns of temporomandibular disorders YH Cha, BJ Kim, JH Lim, KH Park, HG Kim, JK Huh Journal of the Korean Association of Oral and Maxillofacial Surgeons 36 (6 …, 2010 | 9 | 2010 |
Woong NamYonsei university在 yuhs.ac 的电子邮件经过验证
